Your session is about to expire
← Back to Search
Experimental: RF Device Arm for Acne Scars
Study Summary
This trial tested a laser device to treat acne scars on darker skin tones. Results showed it was safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 65 years old and in good health.I have acne scars on my face and am willing to try a new treatment.I have an infection or an open wound in the area that needs treatment.I take medication that makes my skin more sensitive to sunlight.I have moles that could turn into skin cancer.I am not pregnant, using effective birth control, or planning to become pregnant during the study.I have taken Accutane or similar medication in the past 6 months.I am between 18 and 65 years old and in good health.I have had skin cancer or suspicious skin lesions in the area to be treated.I can attend all required visits for the trial.I am on medication that affects how my wounds heal.You have a history of keloid formation.You have very dark skin (type V or VI).I have a serious illness like lupus.You are currently participating in or have recently taken part in a trial for an experimental drug or device in the same area being studied, within the last 6 months.I have been treated with gold therapy.You have a medical condition or are in a situation that could put you at risk, make the study results unclear, or affect your ability to participate in the study.I have acne scars on my face and am willing to try a new treatment.I have not been exposed to the sun without protection or used tanning products in the last 4 weeks.You have epilepsy that is triggered by flashing lights.You are very sensitive to light in the near infrared range.You have a history of a weakened immune system or an autoimmune disease.I have a blood clotting disorder or I'm on blood thinners, including high-dose aspirin.A skin type V or VI is someone who has a very light skin color and is very sensitive to the sun.I can attend all required appointments.Agrees not to have any other procedures on the treatment area during the course of the study.
- Group 1: Alexandrite Laser
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any age restrictions for participation in this trial?
"For this particular trial, only people aged between 18 and 65 are eligible to apply. Separately, 16 trials have been created specifically for participants under the age of 18 while an additional 18 studies cater to individuals above 65 years old."
What qualifications must one possess in order to be accepted into this clinical trial?
"To participate in this dermatology study, participants must have been diagnosed with acne and aged between 18-65. Approximately 25 individuals are being enrolled for clinical research purposes."
Is the recruitment of participants still underway for this clinical trial?
"Affirmative. Clinicaltrials.gov data reveals that the trial, which was first made available on March 8th 2021, is actively recruiting participants. 25 individuals are being sought out at a single site of research."
How many volunteers have enrolled in the research project?
"Affirmative. Records available on clinicaltrials.gov display that this trial, which was originally advertised in March 2021, is now actively recruiting participants. 25 individuals are needed to be sought from a single medical centre."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger